2022 Full Event Guide

The  3rd JAK Inhibitors Drug Development Summit is the only industry-dedicated meeting that considers end-to-end JAK inhibitor focused drug development for autoimmune/autoinflammatory conditions and beyond, to improve accessibility and efficacy of patient care across the globe. 

Uncover JAK selective dosing for novel indications, explore best-in-class approaches to overcome the FDA regulatory hurdles, understand the move towards precision medicine and achieve large-scale manufacture for commercial success.